A Dual Enhancing Strategy of Novel Nanovaccine Based on TIM3 Silencing Nanoadjuvants and Desialylated Cancer Cell Membrane Antigens for Personalized Vaccination Immunotherapy of Cancer

Kaiming Li & Huae Xu et al. · 2024

7Citations
Links
TL;DR

The dClip‐LNP/siRNA significantly silences TIM3 expression in DCs and promotes antigen presentation by DCs and induces robust and durable anti‐tumor immunity in tumor sites to eliminate established B16‐OVA tumors, prevent tumor occurrence, and suppress tumor lung metastasis.

AI-generated by Semantic Scholar

Authors
Kaiming Li, Xiaolin Li, Jie Wu, Haisi Wu, Min Wu, Yupeng Zhou, Ya Lin, Yifan Zou, Xiqun Jiang, Huae Xu